Rhumbline Advisers Bio Techne Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Bio Techne Corp stock. As of the latest transaction made, Rhumbline Advisers holds 261,775 shares of TECH stock, worth $18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
261,775
Previous 272,122 3.8%
Holding current value
$18 Million
Previous $19.5 Million 7.29%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$70.96 - $82.35 $734,223 - $852,075
-10,347 Reduced 3.8%
261,775 $20.9 Million
Q2 2024

Aug 01, 2024
SELL
$62.12 - $84.15 $1.68 Million - $2.27 Million
-26,997 Reduced 9.03%
272,122 $19.5 Million
Q1 2024

May 09, 2024
BUY
$65.98 - $77.09 $91,316 - $106,692
1,384 Added 0.46%
299,119 $21.1 Million
Q4 2023

Feb 08, 2024
SELL
$52.83 - $78.22 $23,509 - $34,807
-445 Reduced 0.15%
297,735 $23 Million
Q3 2023

Nov 09, 2023
SELL
$67.52 - $89.42 $3.33 Million - $4.4 Million
-49,257 Reduced 14.18%
298,180 $20.3 Million
Q2 2023

Aug 08, 2023
BUY
$73.76 - $85.98 $261,331 - $304,627
3,543 Added 1.03%
347,437 $28.4 Million
Q1 2023

May 11, 2023
BUY
$71.62 - $86.62 $1.68 Million - $2.03 Million
23,480 Added 7.33%
343,894 $25.5 Million
Q4 2022

Feb 14, 2023
BUY
$80.67 - $352.29 $19.6 Million - $85.4 Million
242,398 Added 310.7%
320,414 $26.6 Million
Q3 2022

Nov 10, 2022
BUY
$282.54 - $391.85 $630,629 - $874,609
2,232 Added 2.95%
78,016 $22.2 Million
Q2 2022

Aug 11, 2022
BUY
$322.67 - $449.65 $524,016 - $730,231
1,624 Added 2.19%
75,784 $26.3 Million
Q1 2022

May 12, 2022
BUY
$353.85 - $487.79 $266,802 - $367,793
754 Added 1.03%
74,160 $32.1 Million
Q4 2021

Feb 10, 2022
BUY
$456.15 - $525.06 $672,365 - $773,938
1,474 Added 2.05%
73,406 $38 Million
Q3 2021

Nov 12, 2021
SELL
$444.87 - $538.88 $19.4 Million - $23.5 Million
-43,669 Reduced 37.78%
71,932 $34.9 Million
Q2 2021

Aug 05, 2021
SELL
$387.35 - $450.26 $1.04 Million - $1.21 Million
-2,692 Reduced 2.28%
115,601 $52.1 Million
Q1 2021

May 06, 2021
SELL
$314.62 - $411.0 $793,471 - $1.04 Million
-2,522 Reduced 2.09%
118,293 $45.2 Million
Q4 2020

Feb 10, 2021
SELL
$246.9 - $321.87 $919,455 - $1.2 Million
-3,724 Reduced 2.99%
120,815 $38.4 Million
Q3 2020

Nov 12, 2020
SELL
$232.22 - $282.96 $2.66 Million - $3.24 Million
-11,435 Reduced 8.41%
124,539 $30.9 Million
Q2 2020

Aug 13, 2020
BUY
$185.43 - $279.56 $1.72 Million - $2.6 Million
9,295 Added 7.34%
135,974 $35.9 Million
Q1 2020

May 06, 2020
BUY
$161.17 - $221.51 $978,785 - $1.35 Million
6,073 Added 5.04%
126,679 $24 Million
Q4 2019

Feb 05, 2020
SELL
$189.68 - $222.09 $161,417 - $188,998
-851 Reduced 0.7%
120,606 $26.5 Million
Q3 2019

Oct 23, 2019
SELL
$183.56 - $216.72 $425,675 - $502,573
-2,319 Reduced 1.87%
121,457 $23.8 Million
Q2 2019

Aug 14, 2019
SELL
$188.72 - $215.43 $215,518 - $246,021
-1,142 Reduced 0.91%
123,776 $25.8 Million
Q1 2019

May 01, 2019
SELL
$136.09 - $200.44 $464,475 - $684,101
-3,413 Reduced 2.66%
124,918 $24.8 Million
Q4 2018

Jan 31, 2019
BUY
$132.75 - $203.8 $3.59 Million - $5.51 Million
27,014 Added 26.66%
128,331 $18.6 Million
Q3 2018

Nov 07, 2018
BUY
$147.44 - $204.11 $273,943 - $379,236
1,858 Added 1.87%
101,317 $20.7 Million
Q2 2018

Aug 06, 2018
SELL
$144.9 - $165.58 $50,715 - $57,953
-350 Reduced 0.35%
99,459 $14.7 Million
Q1 2018

May 02, 2018
BUY
$131.46 - $151.04 $1.41 Million - $1.62 Million
10,719 Added 12.03%
99,809 $15.1 Million
Q4 2017

Feb 09, 2018
SELL
$121.17 - $134.75 $185,026 - $205,763
-1,527 Reduced 1.69%
89,090 $11.5 Million
Q3 2017

Nov 06, 2017
BUY
$113.59 - $123.78 $10.3 Million - $11.2 Million
90,617
90,617 $11 Million

Others Institutions Holding TECH

# of Institutions
601
Shares Held
151M
Call Options Held
195K
Put Options Held
53.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.7B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email